Recombinant adenovirus as a fast-acting universal influenza A vaccine

National Institute Of Allergy And Infectious Diseases

Investigators

Abstract

Provide a more rapid approach to containing influenza threats than measures based on the hemagglutinin (HA) and neuraminidase (NA) of particular strains.